The Global Veterinary Vaccines Market to grow from USD 9.28 billion in 2022 to USD 15.19 billion by 2030, at a CAGR of 6.35%.

PUNE, MAHARASHTRA, INDIA , November 17, 2023 /EINPresswire.com/ -- The "Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

The Global Veterinary Vaccines Market to grow from USD 9.28 billion in 2022 to USD 15.19 billion by 2030, at a CAGR of 6.35%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/veterinary-vaccines?utm_source=einpresswire&utm_medium=referral&utm_campaign=sample

Veterinary vaccines are biologically prepared substances that stimulate an animal's immune system to protect it from specific diseases. These vaccines function similarly to human vaccines by introducing antigens, typically inactivated or attenuated forms of pathogens or their components, into the animal's body. This exposure triggers an immune response, including producing antibodies, memory cells, and other defense mechanisms, so the animal can develop immunity to the targeted disease without getting sick. Increasing pet adoption, livestock population, rising awareness of zoonotic diseases, surging incidences of animal diseases, and escalating investments in animal health drive further growth. However, the high cost of vaccine storage and difficulties in maintaining the viability of vaccines during transport pose significant issues in the market expansion. The increasing count of in-house pets escalated the focus on food safety, and advancements in biotechnological research provide significant opportunities in the market.

Animal Type: Rising usage of vaccines for disease prevention in livestock animals
Aquaculture utilizes vaccines to ensure the health and productivity of aquatic species. The need for vaccines has increased in recent years due to the growing prevalence of diseases in both marine and freshwater environments. Fish health issues have led farmers to opt for vaccines, driving a preference for inactivated and toxic vaccines. The vaccine requirements for companion animals are largely preventive, ensuring the well-being of pets such as cats, dogs, and birds. Livestock vaccination is crucial for the avoidance of disease outbreaks, the protection of animal health, and the sustenance of productivity in the meat and dairy industries.

Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
Intravenous administration, directly introducing the vaccine into the bloodstream, garners immediate immune response, largely practiced in emergency situations. Nasal administration offers ease of use and comfort for animals, often pragmatically applied in kennels and shelters. Oral administration, a non-invasive route, is largely preferred for domestic pets due to the minimal stress involved. Intravenous administration is highly effective with an immediate response, and nasal administration is highly favored for respiratory diseases Oral administration is stress-free and handy for pet owners and is contraindicated in animals with gastrointestinal disorders.

Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
Inactivated vaccines, also known as killed vaccines, are composed of virus particles, bacteria, and other pathogens that have been grown in culture and then killed. These vaccines are often employed in veterinary practices where live viruses pose a risk. They are specifically designed to target diseases such as rabies, influenza, and leptospirosis. Live attenuated vaccines are powerful tools in controlling infectious diseases in animals. They contain a version of the living microbe that has been altered so it cannot cause serious disease. They closely mimic natural infections and offer prolonged, usually lifelong immunity. Recombinant vaccines use a small piece of genetic material from a pathogen to stimulate an immune response. They offer enhanced safety and efficacy and are especially useful in the fight against infectious diseases such as Equine Influenza, Lyme Disease, and Avian Influenza. Toxoid vaccines are made from a toxin that has been made harmless, but that provokes an immune response against the toxin. These are ideally used to immunize against diseases that are caused by bacteria-release toxins.

Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
Veterinary hospitals & clinics are often the preferred channels for the distribution of veterinary vaccines. Given the complexity and nuanced understanding needed for proper vaccination, clients typically lean toward professional veterinary environments. Veterinarians, who are equipped with the knowledge and experience to administer vaccines, lend credibility and assurance to this provision. With the rise of at-home pet care, retail pharmacies have grown in popularity as a distribution channel for veterinary vaccines. Pet owners conveniently purchase vaccines along with other pet necessities. Retail pharmacies typically carry a variety of vaccines suitable for common household pets such as cats and dogs.

Regional Insights:
The Americas exhibits the highest adoption of veterinary vaccines, primarily due to the high animal population and increasing awareness of animal health. Various regulations and guidelines set by local animal health organizations have substantially driven vaccine adoption. In EMEA, Europe leads in adopting veterinary vaccines owing to the region's advanced medical and technological infrastructure, robust regulatory frameworks, and initiatives promoting animal welfare, significantly contributing to this growth. In the Middle East and Africa, increasing investments and efforts towards improving animal health care systems signify growth potential. APAC, home to a large livestock population and high pet ownership, presents significant potential for veterinary vaccine adoption. Rapid urbanization and increasing pet adoption rates facilitate market expansion alongside governmental directives on disease prevention. The APAC Countries have been increasingly focusing on animal health as urban areas report high vaccine adoption due to increasing companion animal ownership and awareness.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Veterinary Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Veterinary Vaccines Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/veterinary-vaccines?utm_source=einpresswire&utm_medium=referral&utm_campaign=inquire

Market Segmentation & Coverage:

This research report categorizes the Veterinary Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Animal Type, market is studied across Aquaculture, Companion Animals, and Livestock. The Livestock is further studied across Bovine, Porcine, Poultry, and Small Ruminants. The Aquaculture is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines. The Live Attenuated Vaccines is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Intravenous, Nasal, and Oral. The Nasal is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospitals & Clinics and Retail Pharmacies. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 36.82% in 2022, followed by Asia-Pacific.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Veterinary Vaccines Market, by Animal Type
7. Veterinary Vaccines Market, by Technology
8. Veterinary Vaccines Market, by Route of Administration
9. Veterinary Vaccines Market, by Distribution Channel
10. Americas Veterinary Vaccines Market
11. Asia-Pacific Veterinary Vaccines Market
12. Europe, Middle East & Africa Veterinary Vaccines Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Veterinary Vaccines Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Veterinary Vaccines Market?
3. What is the competitive strategic window for opportunities in the Veterinary Vaccines Market?
4. What are the technology trends and regulatory frameworks in the Veterinary Vaccines Market?
5. What is the market share of the leading vendors in the Veterinary Vaccines Market?
6. What modes and strategic moves are considered suitable for entering the Veterinary Vaccines Market?

Read More @ https://www.360iresearch.com/library/intelligence/veterinary-vaccines?utm_source=einpresswire&utm_medium=referral&utm_campaign=analyst

Mr. Ketan Rohom
360iResearch
+ 1 530-264-8485
ketan@360iresearch.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.